Log In
Print
BCIQ
Print
Print this Print this
 

Lyme disease vaccine

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionMultivalent recombinant outer surface protein A (OspA) Lyme Borreliosis vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationLyme disease
Indication DetailsPrevent Lyme disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today